Advertisement - see our Ad Policy
Advertisement - see our Ad Policy

RestoreX Penile Traction Therapy – Review

0
Advertisement

Peyronie’s Disease (PD) is a condition which produces scar tissue within the penis. This in turn can can cause curved, painful erections, loss of penis length, difficulty ejaculating, and difficulty urinating. Treatments for PD include drugs, shockwave therapy, and surgery.

In several clinical studies1 2, doctors have used penile traction therapy (PTT) devices to attempt to straighten the curvature of the penis and restore lost length to men with Peyronie’s Disease. (Separate studies3 4 have found that penile traction devices can increase penis length among men in general.)

The traction devices used in these studies were uncomfortable and difficult to adjust. The protocols required subjects to wear the traction devices for several hours each day, over a period of several months. As a result, few subjects completed the treatment programs.

The RestoreX® penile traction therapy device was developed by a board-certified urologist specializing in Men’s Sexual Health, in cooperation with the Mayo Clinic, to address these issues.

To improve the comfort of the device, the company designed a new clamp to spread the pressure evenly over the head of the penis, and a larger pelvic ring to disperse forces over a greater area for enhanced comfort.

The device also features an innovative adjustable tension system.  The ability to add length and thereby tension while the device is worn is critically important to accommodate the tissue stretch that occurs during the first few minutes of the 30-minute treatment time.  As the tissue stretches, also called stretch relaxation, RestoreX can be adjusted while worn to maintain the required level of traction.  

RestoreX Clinical Results

As a result of these innovations, doctors have been able to reduce treatment time to two 30-minute sessions per day. Clinical studies5 6 of treatment programs for patients with Peyronie’s Disease – over periods of three months and six months – found significant reduction in curvature and increase of penis length.

Results of a three-month treatment study, reported on the company’s website, found:

  • A 28% reduction in curvature
  • A 1.6 cm increase in penis length
  • A 4.3 point improvement in IETF scores for men in the trial that had an overall IIEF score of less than 25 (some amount of erectile dysfunction).

Researchers have also reported significant improvements in penis length and erectile function in post-prostatectomy men7.

Conclusions

The design innovations in the RestoreX traction device offer significant improvements in user comfort and in treatment effectiveness. The effectiveness of the device in treating post-prostatectomy patients and Peyronie’s Disease patients is well documented in a number of clinical studies.

The device sells for $499, and is FSA/HSA eligible with a prescription.

For more information on the RestoreX, visit https://www.restorex.com/.

RestoreX is a registered trademark of PathRight Medical Inc.


References

  1. Valenzuela, Robert; Ziegelmann, Matthew; Tokar, Sam; Hillelsohn, Joel. “The use of penile traction therapy in the management of Peyronie’s disease: current evidence and future prospects.” Therapeutic Advances in Urology. Mar 2019. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6444402/>
  2. Chung, Eric; Brock, Gerald. “Penile traction therapy and Peyronie’s disease: a state of art review of the current literature.” Therapeutic Advances in Urology. Feb 2013. <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3547530/>
  3. Nowroozi, M R; Amini, E; Ayati, M; Jamshidian, H; Radkhah, K; Amini, S. “Applying extender devices in patients with penile dysmorphophobia: assessment of tolerability, efficacy, and impact on erectile function.” Journal of Sexual Medicine. May 2015. 12(5):1242-7. <https://www.jsm.jsexmed.org/article/S1743-6095(15)31027-4/fulltext>
  4. Gontero, P; Di Marco, M; Giubilei, G; Bartoletti, R; Pappagallo, G; Tizzani, A; Mondaini, N. “A pilot phase-II prospective study to test the ‘efficacy’ and tolerability of a penile-extender device in the treatment of ‘short penis’.” BJU International. Mar 2009. 103(6):793-7. <https://www.ncbi.nlm.nih.gov/pubmed/18990153/>
  5. Ziegelmann, Matthew; Savage, Josh; Toussi, Amir; Alom, Manaf; Yang, David; Kohler, Tobias; Trost, Landon. “Outcomes of a Novel Penile Traction Device in Men with Peyronie’s Disease: A Randomized, Single-Blind, Controlled Trial.” Journal of Urology. Sep 2019. 202(3):599-610. <https://pubmed.ncbi.nlm.nih.gov/30916626/>
  6. Joseph, Jason; Ziegelmann, Matthew J.; Alom, Manaf; Savage, Joshua; Köhler, Tobias S; Trost, Landon. “Outcomes of RestoreX Penile Traction Therapy in Men With Peyronie’s Disease: Results From Open Label and Follow-up Phases.” The Journal of Sexual Medicine. Dec 2020. Vol 17, #12, P2462-2471.
    <https://www.jsm.jsexmed.org/article/S1743-6095(20)30939-5/fulltext>
  7. Yang, D; Ziegelmann, M; Manka, M; et al. “Efficacy of RestoreX penile traction therapy in improving penile length and erectile function post prostatectomy.” Abstract presented at: 2020 Sexual Medicine Society of North America Annual Fall Scientific Meeting; November 9-15, 2020; Virtual. Session 5.
    <https://www.urologytimes.com/view/penile-traction-therapy-improves-post-prostatectomy-penile-length-erectile-function>

Comments are closed.